Efficacy and Safety of Pulse Steroid Therapy in Japanese Pediatric Patients with Ulcerative Colitis: A Survey of the Japanese Society for Pediatric Inflammatory Bowel Disease

被引:5
作者
Nagata, Satoru [1 ]
Shimizu, Toshiaki [1 ]
Kudo, Takahiro [1 ]
Tomomasa, Takeshi [2 ]
Tajiri, Hitoshi [3 ]
Yoden, Atsushi [4 ]
Kagimoto, Seiichi [5 ]
Tahara, Takuji [6 ]
Ushijima, Kohsuke [7 ]
Uchida, Keiichi [8 ]
Kobayashi, Akio [9 ]
机构
[1] Juntendo Univ, Sch Med, Dept Pediat, Tokyo 1138421, Japan
[2] Pal Kodomo Clin, Gunma, Japan
[3] Osaka Gen Med Ctr, Dept Pediat, Osaka, Japan
[4] Osaka Med Coll, Dept Pediat, Osaka, Japan
[5] Saitama Childrens Med Ctr, Dept Gen Pediat, Saitama, Japan
[6] Tahara Clin, Yamaguchi, Japan
[7] Kurume Univ, Med Ctr, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan
[8] Mie Univ Hosp, Dept Surg, Tsu, Mie, Japan
[9] Showa Univ, Toyosu Clin, Dept Pediat, Tokyo, Japan
关键词
Ulcerative colitis; Pulse steroid therapy; Children; Japan; SEVERE ATTACKS; PREDNISOLONE; METHYLPREDNISOLONE; PHARMACOKINETICS; CHILDREN; TRIAL;
D O I
10.1159/000255379
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims: We have evaluated the therapeutic efficacy and safety of pulse steroid therapy for ulcerative colitis (UC) in a Japanese pediatric population by means of a survey. Methods: A questionnaire on UC patients treated with therapy between 2002 and 2006 was sent to 37 members of the Japanese Society for Pediatric Inflammatory Bowel Disease. Results: 21 of 62 cases in 6 of 19 centers registered in this study had been treated with pulse steroid therapy. The success rate of remission induction with this treatment was 55%, and improvement was observed in all cases in which remission was not achieved. There were no reports of any obvious side effects. The most common reason for using pulse steroid therapy was for remission induction in relapsed cases. Over the course of 12 (or fewer) months, the number of cases in which remission was maintained was only 1 in 4. However, the amount of concomitant steroid use had significantly decreased after 1 year. Conclusions: This survey shows that in Japan, pulse steroid therapy is used for a relatively large number of children with UC and is as an effective method of remission induction that has few side effects. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:188 / 192
页数:5
相关论文
共 17 条
[1]  
[Anonymous], BR MED B, DOI DOI 10.1093/BMB/LDL001]
[2]   Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects [J].
Lebrun-Vignes, B ;
Archer, VC ;
Diquet, B ;
Levron, JC ;
Chosidow, O ;
Puech, AJ ;
Warot, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (05) :443-450
[3]   PHARMACOKINETICS OF PREDNISOLONE IN CHILDREN WITH NEPHROSIS [J].
MILLER, PFW ;
BOWMER, CJ ;
WHEELDON, J ;
BROCKLEBANK, JT .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (02) :196-200
[4]   PLASMA PREDNISOLONE LEVELS FROM ENTERIC AND NON-ENTERIC COATED TABLETS ESTIMATED BY AN ORIGINAL TECHNIQUE [J].
MORRISON, PJ ;
BRADBROOK, ID ;
ROGERS, HJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (05) :597-603
[5]   Outpatient treatment of moderately severe active ulcerative colitis with pulsed steroid therapy and conventional steroid therapy [J].
Oshitani, N ;
Kamata, N ;
Ooiso, R ;
Kawashima, D ;
Inagawa, M ;
Sogawa, M ;
Iimuro, M ;
Jinno, Y ;
Watanabe, K ;
Higuchi, K ;
Matsumoto, T ;
Arakawa, T .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (05) :1002-1005
[6]   Prediction of short-term outcome for patients with active ulcerative colitis [J].
Oshitani, N ;
Matsumoto, T ;
Jinno, Y ;
Sawa, Y ;
Hara, J ;
Nakamura, S ;
Arakawa, T ;
Kitano, A ;
Kuroki, T .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (05) :982-986
[7]   HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF ACTIVE ULCERATIVE-COLITIS [J].
ROSENBERG, W ;
IRELAND, A ;
JEWELL, DP .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1990, 12 (01) :40-41
[8]   Pulse steroids for ulcerative colitis: Good news, bad news, and no news [J].
Sachar, DB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (04) :291-292
[9]  
SEO M, 1992, AM J GASTROENTEROL, V87, P971
[10]   A prospective, open-label trial assessing dexamethasone pulse therapy in moderate to severe ulcerative colitis [J].
Sood, A ;
Midha, V ;
Sood, N ;
Awasthi, G .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (04) :328-331